Keeping Cancer Cures a Corporate Profit Center

Sam Pizzigati

Sam Pizzigati Editor, Too Much online magazine

Who knew fighting cancer could be so lucrative? Memorial Sloan Kettering Cancer Center CEO Craig Thompson, for one. Last year, Thompson pulled down nearly $600,000 in cash and stock from his service on two for-profit drug company boards, all on top of his $6.7 million in Sloan Kettering pay the year before. No wonder Thompson looked the other way while his chief medical officer “failed to disclose” in medical journal articles that he had received millions from companies that could be banking on matters he was writing about. In September, that scandal went public, and Thompson at first insisted that working with for-profit companies must remain a priority. Last week, amid mounting public outrage, Thompson retreated and announced he would resign his corporate board seats. But the real scandal remains: a hospital-Big Pharma complex that focuses single-mindedly on patentable pharmaceuticals that generate huge returns for corporate execs and shareholders.

Sam Pizzigati edits Too Much, the online weekly on excess and inequality. He is an associate fellow at the Institute for Policy Studies in Washington, D.C. Last year, he played an active role on the team that generated The Nation magazine special issue on extreme inequality. That issue recently won the 2009 Hillman Prize for magazine journalism. Pizzigati’s latest book, Greed and Good: Understanding and Overcoming the Inequality that Limits Our Lives (Apex Press, 2004), won an “outstanding title” of the year ranking from the American Library Association’s Choice book review journal.

Posted In: Union Matters

Union Matters

A Billionaire with a Truly Bottom-Line Moral Code

Sam Pizzigati

Sam Pizzigati Editor, Too Much online magazine

Some advice for billionaire investment fund manager Tom Barrack: Don’t give any more lectures on morality. Last Tuesday, this long-time Donald Trump pal — and chairman of his inauguration — did a bit too much moralizing. Speaking in Abu Dhabi, Barrack called the hand-wringing over Saudi crown prince Mohammed bin Salman’s role in the savage murder of Washington Post columnist Jamal Khashoggi “a mistake.” After all, he noted, “we have a young man and a regime that’s trying to push themselves into 2030.” We ought not, Barrack added, try “to dictate” the Saudi “moral code.” The pushback would be quick and massive. On Wednesday, Barrack apologized, but didn’t, news reports noted, “retract praise for the crown prince.” One possible reason: Barrack’s investment fund has tanked of late, its share price down by over half. Barrack has raised over $1.5 billion in bailout aid from Saudi Arabia and the UAE. He may be hoping for still more.

***

More ...

Let's Talk About Wealth

Let's Talk About Wealth